FDA recall Z-1245-2023

Maquet Cardiovascular, LLC · Class II · device

Product

Fusion Bioline Vascular Graft, Part number M00201503046B0

Reason for recall

One (1) Fusion Bioline Vascular graft from lot 25162546, which failed guideline straightness testing, was intermingled with lot 25162549 and distributed to customers. Use of the affected graft may result in reduction of blood flow or unwanted tension causing bleeding and the formation of a pseudo-aneurysm.

Distribution

US Nationwide distribution in the states of FL, IN, LA, MI, MO, NC, NV, NY, PA, TN, TX, VA, WA.

Key facts

Status
Ongoing
Initiation date
2023-01-30
Report date
2023-03-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Wayne, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1245-2023